Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug
Public ClinicalTrials.gov record NCT04534114. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Factor XI LICA to Reduce Thrombotic Events in End-Stage Renal Disease Patients on Hemodialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of BAY 2976217
Study identification
- NCT ID
- NCT04534114
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bayer
- Industry
- Enrollment
- 307 participants
Conditions and interventions
Interventions
- Fesomersen sodium (BAY2976217) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 3, 2020
- Primary completion
- Jan 23, 2022
- Completion
- May 11, 2022
- Last update posted
- Jul 2, 2023
2020 – 2022
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Fresenius Kidney Care Clovis | Clovis | California | 93611 | — |
| Desert Cities Dialysis-Amethyst & Desert Cities Dialysis | Victorville | California | 92392 | — |
| Davita East Ft. Lauderdale Dialysis Center | Fort Lauderdale | Florida | 33316 | — |
| Fresenius Kidney Care St. Louis Regional Dialysis | Saint Ann | Missouri | 63074 | — |
| Chromalloy Dialysis Center | St Louis | Missouri | 63110 | — |
| Fresenius Medical Care - Fire Mesa Dialysis Unit | Las Vegas | Nevada | 89128 | — |
| DaVita Northwest Medical Center Dialysis | San Antonio | Texas | 78229 | — |
| San Antonio Kidney Disease Center Physicians Group, PLLC | San Antonio | Texas | 78258 | — |
| Salem VA Medical Center | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04534114, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2023 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04534114 live on ClinicalTrials.gov.